Bristol-Myers and Celgene CEOs talk acquisition deal

Bristol-Myers Squibb chairman and CEO Dr. Giovanni Caforio and Celegene Chairman and CEO Mark Alles sit down with CNBC's Jim Cramer to discuss their recently announced acquisition deal.
08:22
Mon, Jan 7 20199:42 AM EST